- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
- 10-K Annual report
- 10.6 Third Amendment to Sublease Agreement
- 10.42 Agreement to Modify the Corporation's Compensation Arrangement
- 10.43 Amendment No. 1 to the Agreement to Modify the Corporation's Compensation Arr.
- 10.44 Agreement to Bonus Payment and Contingent Bonus Payment
- 12.1 Statement Re: Computation of Ratio of Earnings to Fixed Charges
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Stonefield Josephson, Inc.
- 23.2 Consent of Grant Thornton LLP
- 31.1 Certification of Chief Executive Officer
- 31.2 Certification of Chief Financial Officer
- 32 Certification of Chief Executive Officer and Chief Financial Officer
Exhibit 10.44
Authorization of Bonus and Contingent Bonus Payment.
On July 10, 2006, the Compensation Committee (the “Committee”) of Cell Therapeutics, Inc. (the “Corporation”) authorized the payment of a bonus of $169,952 to James A. Bianco, M.D., the Corporation’s President and Chief Executive Officer. The Committee also authorized the payment of a contingent bonus of $169,952 to Dr. Bianco payable if the Corporation achieves, on or before September 30, 2006, its long-standing corporate objective of closing a material collaboration transaction with a pharmaceutical company, subject to certain conditions.
-1-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CELL THERAPEUTICS, INC. | ||||||||
Date: July 14, 2006 | By: | /s/ James A. Bianco | ||||||
James A. Bianco, M.D. | ||||||||
President and Chief Executive Officer |